• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

[Mesoblast] MESOBLAST LIMITED : MSB ASX NEW DIRECTOR - 10 MAY 2012


  • Please log in to reply
252 replies to this topic

#61 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 24 May 2012 - 12:35 AM

VSE Wins Multiple Award Health and Information Technology Contracts; Celldex's ...
BioMedReports (subscription) - 1 hour ago
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on May 23, 2012.

View the full article

#62 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 23 May 2012 - 12:51 PM

BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards ...
EON: Enhanced Online News (press release) - 20 hours ago
ALAMEDA, Calif. & CAMBRIDGE, Mass.--(EON: Enhanced Online News)--XenneX, a Division of LifeMap Sciences, Inc. and BioTime, Inc. (NYSE Amex:BTX), announced today the release of GeneCards®, Version 3.08, on May 20, 2012.

View the full article

#63 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 23 May 2012 - 02:40 AM

This Just In: More Upgrades and Downgrades
DailyFinance - May 23, 2012
By Rich Smith (TMFDitty), The Motley Fool At The Motley Fool, we poke plenty of fun at Wall Street analysts and their endless cycle of upgrades, downgrades, and "initiating coverage at neutral.

View the full article

sponsored ad

  • Advert

#64 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 24 May 2012 - 05:54 PM

“Where's the beef”, OSIR recaptures gain as sector wavers
Proactive Investors USA & Canada - 1 hour ago
Mid-Day Market Commentary: RegMed stocks struggle for direction showing a very slow recovery - if any. Stocks have basically … moved in a flat line in mid-day trading on Thursday.

View the full article

#65 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 24 May 2012 - 12:35 AM

VSE Wins Multiple Award Health and Information Technology Contracts; Celldex's ...
BioMedReports (subscription) - 18 hours ago
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on May 23, 2012.

View the full article

#66 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 23 May 2012 - 06:48 PM

US FDA Staff Shoot Down Pfizer Rare Disease Drug; Repros Updates Special ...
Proactive Investors USA & Canada - May 23, 2012
Below is a look at some of the headlines for companies that made news in the healthcare sector on May 22, 2012. US drug reviewers recommended on Tuesday rejecting a Pfizer Inc (NYSE:PFE) drug because the data did not prove it worked well in treating a ...

View the full article

#67 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 23 May 2012 - 12:46 PM

BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards(R ...
MarketWatch (press release) - May 23, 2012
ALAMEDA, Calif. & CAMBRIDGE, Mass., May 23, 2012 (BUSINESS WIRE) -- XenneX, a Division of LifeMap Sciences, Inc. and BioTime, Inc. (nyse amex:BTX), announced today the release of GeneCards®, Version 3.08, on May 20, 2012.
BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards ... - SYS-CON Media (press release)

View the full article

#68 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 23 May 2012 - 02:09 AM

US FDA Staff Shoot Down Pfizer Rare Disease Drug; Repros Updates Special ...
BioMedReports (subscription) - May 23, 2012
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on May 22, 2012.

View the full article

#69 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 22 May 2012 - 12:03 AM

Merck HIV Trial Vaccine Stopped; J&J's Xarelto Cited for Missing Data
BioMedReports (subscription) - May 22, 2012
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on May 21, 2012.

View the full article

#70 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 24 May 2012 - 05:54 PM

“Where's the beef”, OSIR recaptures gain as sector wavers
Proactive Investors USA & Canada - 2 hours ago
Mid-Day Market Commentary: RegMed stocks struggle for direction showing a very slow recovery - if any. Stocks have basically … moved in a flat line in mid-day trading on Thursday.

View the full article

#71 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 23 May 2012 - 06:48 PM

US FDA Staff Shoot Down Pfizer Rare Disease Drug; Repros Updates Special ...
Proactive Investors USA & Canada - May 23, 2012
Below is a look at some of the headlines for companies that made news in the healthcare sector on May 22, 2012. US drug reviewers recommended on Tuesday rejecting a Pfizer Inc (NYSE:PFE) drug because the data did not prove it worked well in treating a ...

View the full article

#72 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 23 May 2012 - 01:17 PM

BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards ...
Genetic Engineering News (press release) - May 23, 2012
XenneX, a Division of LifeMap Sciences, Inc. and BioTime, Inc. (NYSE Amex:BTX), announced today the release of GeneCards®, Version 3.08, on May 20, 2012.

View the full article

#73 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 29 May 2012 - 06:23 PM

Hope fading but, will prayers work for a return of focus to sector?
Proactive Investors USA & Canada - 17 hours ago
Mid-Day Market Commentary: Some … RegMed stocks extended a few gains on Tuesday … as investors haven't quite shrugged off worries over the euro zone and despite some tepid economic reports.

View the full article

#74 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 29 May 2012 - 06:23 PM

Hope fading but, will prayers work for a return of focus to sector?
Proactive Investors USA & Canada - 19 hours ago
Mid-Day Market Commentary: Some … RegMed stocks extended a few gains on Tuesday … as investors haven't quite shrugged off worries over the euro zone and despite some tepid economic reports.

View the full article

#75 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 30 May 2012 - 12:47 PM

BioTime CEO Dr. Michael West to Present at the Jefferies 2012 Global ...
MarketWatch (press release) - 2 hours ago
ALAMEDA, Calif., May 30, 2012 (BUSINESS WIRE) -- BioTime, Inc. (nyse mkt:BTX) announced that its Chief Executive Officer, Michael D. West, Ph.

View the full article

#76 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 23 May 2012 - 06:48 PM

US FDA Staff Shoot Down Pfizer Rare Disease Drug; Repros Updates Special ...
Proactive Investors USA & Canada - May 23, 2012
Below is a look at some of the headlines for companies that made news in the healthcare sector on May 22, 2012. US drug reviewers recommended on Tuesday rejecting a Pfizer Inc (NYSE:PFE) drug because the data did not prove it worked well in treating a ...

View the full article

#77 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 31 May 2012 - 01:17 AM

Alkermes Announces Results from Phase 2 Study of ALKS 37; Pronova Wins Heart ...
BioMedReports (subscription) - 37 minutes ago
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on May 30, 2012.

View the full article

#78 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 31 May 2012 - 01:17 AM

Alkermes Announces Results from Phase 2 Study of ALKS 37; Pronova Wins Heart ...
BioMedReports (subscription) - 7 hours ago
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on May 30, 2012.

View the full article

#79 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 04 June 2012 - 12:01 PM

Geron to Present at the Jefferies 2012 Global Healthcare Conference
Reuters (press release) - 23 minutes ago
MENLO PARK, Calif., June 4, 2012 - Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, President and Chief Executive Officer, will present an overview of the company at 1:00 pm ET on Wednesday, June 6, at the Jefferies 2012 Global ...

View the full article

#80 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 04 June 2012 - 11:45 AM

Weekly Stock Watch: Week Of June 4, 2012
Seeking Alpha - 40 minutes ago
At the conclusion of each week, VFC's Stock House examines some news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well.

View the full article

#81 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 04 June 2012 - 12:01 PM

Geron to Present at the Jefferies 2012 Global Healthcare Conference
Reuters (press release) - 3 hours ago
MENLO PARK, Calif., June 4, 2012 - Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, President and Chief Executive Officer, will present an overview of the company at 1:00 pm ET on Wednesday, June 6, at the Jefferies 2012 Global ...

View the full article

#82 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 31 May 2012 - 07:53 PM

Alkermes Announces Results from Phase 2 Study of ALKS 37; Pronova Wins Heart ...
Proactive Investors USA & Canada - May 31, 2012
Below is a look at some of the headlines for companies that made news in the healthCAre sector on May 30, 2012. Alkermes plc (NASDAQ: ALKS) announced topline results from a Phase 2b dose-ranging cliniCAl study of ALKS 37 in the treatment of ...

View the full article

#83 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 31 May 2012 - 01:17 AM

Alkermes Announces Results from Phase 2 Study of ALKS 37; Pronova Wins Heart ...
BioMedReports (subscription) - May 31, 2012
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on May 30, 2012.

View the full article

#84 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 30 May 2012 - 12:47 PM

BioTime CEO Dr. Michael West to Present at the Jefferies 2012 Global ...
MarketWatch (press release) - May 30, 2012
ALAMEDA, Calif., May 30, 2012 (BUSINESS WIRE) -- BioTime, Inc. (nyse mkt:BTX) announced that its Chief Executive Officer, Michael D. West, Ph.
BIOTIME, INC. : BioTime CEO Dr. Michael West to Present at the Jefferies 2012 ... - 4-traders

View the full article

#85 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 06 June 2012 - 08:00 PM

An over-sold relief rally, short covering with a short term bounce?
Proactive Investors USA & Canada - 19 hours ago
Mid-Day Market Commentary: Stocks rally… lifting the Dow and NASDAQ back into positive territory for the year, as pressure mounts on policy makers to come up with additional stimulus.

View the full article

#86 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 12 June 2012 - 01:42 AM

Up On A Down Day; 3 Small Caps Between $1 and $2 For Tuesday
Fyxnews - 43 minutes ago
By Jason Bond of JasonBondPicks.com Today's market was a mess to say the least so when you go shopping for swing trades into Tuesday, one strategy I teach is to scan for stocks that bucked the trend and were up on a down day.

View the full article

#87 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 11 June 2012 - 05:15 PM

Cardium (CXM) Engages MissionIR to Expand Investor Awareness
BiotechStockTrader.com - Jun 11, 2012
Cardium Therapeutics (NYSE MKT: CXM), a health sciences and regenerative medicine company focused on the acquisition of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs ...

View the full article

#88 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 11 June 2012 - 05:15 PM

Cardium (CXM) Engages MissionIR to Expand Investor Awareness
BiotechStockTrader.com - Jun 11, 2012
Cardium Therapeutics (NYSE MKT: CXM), a health sciences and regenerative medicine company focused on the acquisition of new and innovative bio-medical ...

View the full article

#89 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 04 June 2012 - 01:21 PM

Three Stocks to See Before You Start the Trading Week: PIP, IMGN ...
SmallCap Network - Jun 4, 2012
Before you do anything else, ImmunoGen, Inc. (NASDAQ:IMGN), ParkerVision, Inc. (NASDAQ:PRKR), and PharmAthene, Inc. (AMEX:PIP) deserve a closer look.

View the full article

#90 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 31 May 2012 - 09:34 PM

Biotech Ideas That Will Change the World: Patrick Cox
International Business Times - May 31, 2012
For Patrick Cox, disruptive technologies drive change and harbor opportunity. Cox, editor of Breakthrough Technology Alert and Technology Profits Confidential, ...

View the full article




0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users